《2018年欧洲肝病学会临床实践指南:酒精性肝病管理》摘译

2018-07-08 临床肝胆病杂志.2018.34(7):1415-1419.

欧洲肝病学会(EASL)理事会批准成立了肝病和酒精相关性肝病(ALD)专业临床医师小组,该小组于2016 年11 月-2017 年3 月撰写并讨论了新的ALD 管理临床实践指南。

中文标题:

《2018年欧洲肝病学会临床实践指南:酒精性肝病管理》摘译

发布机构:

发布日期:

2018-07-08

简要介绍:

欧洲肝病学会(EASL)理事会批准成立了肝病和酒精相关性肝病(ALD)专业临床医师小组,该小组于2016 年11 月-2017 年3 月撰写并讨论了新的ALD 管理临床实践指南。

译者: 厦门大学附属中山医院消化内科 宋阳 周飞(译),陈立刚(审校)

拓展指南:酒精性肝病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=《2018年欧洲肝病学会临床实践指南:酒精性肝病管理》摘译)] GetToolGuiderByIdResponse(projectId=1, id=842881c00161a242, title=《2018年欧洲肝病学会临床实践指南:酒精性肝病管理》摘译, enTitle=, guiderFrom=临床肝胆病杂志.2018.34(7):1415-1419., authorId=null, author=, summary=欧洲肝病学会(EASL)理事会批准成立了肝病和酒精相关性肝病(ALD)专业临床医师小组,该小组于2016 年11 月-2017 年3 月撰写并讨论了新的ALD 管理临床实践指南。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun Jul 08 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>欧洲肝病学会(EASL)理事会批准成立了肝病和酒精相关性肝病(ALD)专业临床医师小组,该小组于2016 年11 月-2017 年3 月撰写并讨论了新的ALD 管理临床实践指南。</div> <div><br> </div>译者: 厦门大学附属中山医院消化内科 宋阳 周飞(译),陈立刚(审校) <div><br> </div> 拓展指南:<strong>与<font color=red>酒精性肝病</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=0d38a1c0015e90dc" title="2018 EASL临床实践指南:酒精性肝病的管理" target=_blank>2018 EASL临床实践指南:酒精性肝病的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=a149b1c0015e8766" title="酒精性肝病防治指南(2018年更新版)" target=_blank>酒精性肝病防治指南(2018年更新版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=89cdd1c0015e50dd" title="《2018 年美国胃肠病学院酒精性肝病诊治临床指南》推荐意见" target=_blank>《2018 年美国胃肠病学院酒精性肝病诊治临床指南》推荐意见</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f3dfb1c0015a6026" title="2018 ACG临床指南:酒精性肝病" target=_blank>2018 ACG临床指南:酒精性肝病</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7ad0a1c0010163db" title="2013 KASL临床实践指南:酒精性肝病的管理" target=_blank>2013 KASL临床实践指南:酒精性肝病的管理</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E9%85%92%E7%B2%BE%E6%80%A7%E8%82%9D%E7%97%85" target=_blank>有关酒精性肝病更多指南</a></ul>, tagList=[TagDto(tagId=307, tagName=酒精性肝病)], categoryList=[CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5206, appHits=134, showAppHits=0, pcHits=3834, showPcHits=1604, likes=151, shares=9, comments=4, approvalStatus=1, publishedTime=Thu Jul 12 21:53:32 CST 2018, publishedTimeString=2018-07-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 12 21:53:32 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:36:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=《2018年欧洲肝病学会临床实践指南:酒精性肝病管理》摘译)])
《2018年欧洲肝病学会临床实践指南:酒精性肝病管理》摘译
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=956175, encodeId=16df9561e540, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:30:56 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331708, encodeId=acc8331e088b, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Jul 15 07:47:12 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331153, encodeId=53303311536a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jul 12 23:06:07 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
    2021-04-12 12584d3cm01暂无昵称

    学习了!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=956175, encodeId=16df9561e540, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:30:56 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331708, encodeId=acc8331e088b, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Jul 15 07:47:12 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331153, encodeId=53303311536a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jul 12 23:06:07 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
    2018-07-15 龙胆草

    学习谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=956175, encodeId=16df9561e540, content=学习了!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210415/bc3ce951b3b649a5b1ca753c4e4958c0/aab00f6f8a78486f86021e6ae795c8e4.jpg, createdBy=85b22571588, createdName=12584d3cm01暂无昵称, createdTime=Mon Apr 12 15:30:56 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331708, encodeId=acc8331e088b, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Sun Jul 15 07:47:12 CST 2018, time=2018-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331153, encodeId=53303311536a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Thu Jul 12 23:06:07 CST 2018, time=2018-07-12, status=1, ipAttribution=)]
    2018-07-12 医者仁心5538

    学习了

    0